Amgen Inc.
Amgen discovers, develops, manufactures, and sells medicines, mainly biologic drugs made from living cells. Its products treat conditions in areas including cardiovascular disease, bone health, oncology, inflammation, and rare diseases. Its medicines include Repatha, Evenity, Prolia, Tepezza, Tezspire, and Krystexxa, several of which came through its 2023 acquisition of Horizon Therapeutics. It also sells biosimilars, which are lower-cost versions of other companies’ biologic drugs. The company reports as a single segment, human therapeutics. Amgen was founded in 1980 as Applied Molecular Genetics, and is headquartered in Thousand Oaks, California.
Connect and whitelist your wallet on Securitize and start trading AMGN tokens instantly.
Go to TradingTradeable assets will be available on leading DeFi protocols.
Amgen discovers, develops, manufactures, and sells medicines, mainly biologic drugs made from living cells. Its products treat conditions in areas including cardiovascular disease, bone health, oncology, inflammation, and rare diseases. Its medicines include Repatha, Evenity, Prolia, Tepezza, Tezspire, and Krystexxa, several of which came through its 2023 acquisition of Horizon Therapeutics. It also sells biosimilars, which are lower-cost versions of other companies’ biologic drugs. The company reports as a single segment, human therapeutics. Amgen was founded in 1980 as Applied Molecular Genetics, and is headquartered in Thousand Oaks, California.
Connect and whitelist your wallet on Securitize and start trading AMGN tokens instantly.
Go to Trading